• Combination Therapy

    Regenetek’s Combination Stem Cell and Vascular Therapy

    read more
  • Regenerative Medicine

    ‎The Most Current Information Available from Leading Scientists and Clinical Trials World-wide

    read more
  • Patient Registry Software

    Application of Technology to Make Any Size of Study Self-Managing and Affordable

    read more
  • Neurodegenerative Disorders

    The Latest Updates on Diseases Treatable Through Regenerative Medicine

    read more
  • Topical Commentary

    Opinions from Regenetek and Leading Authorities in Regenerative Medicine

    read more

Introductory word

Hundreds of thousands of undocumented therapies occur in clinics world-wide each year under the label of ‘medical tourism’. Even if physicians in these clinics wanted to follow their patients, there has been no method of doing so. Until now. Regenetek Research recognizes that there is a high need for a method and a study design that provides proof of both safety and efficacy for new treatment interventions such as autologous stem cell therapies or unsanctioned vascular surgeries. These types of medical interventions present viable choices for patients beyond conventional drug therapies that only treat symptoms. My goal in writing these articles is to point out the gaps in the research while we look for the truth, not reinforce the biases in the science.

WHAT CAN I TAKE? MS Patient’s Medication List Pre and Post Stem Cell Treatment

For the researchers conducting this study, this is the most often asked question of all. When we started this research study a number of years ago, we didn’t know the answer because information on how chemical medications and supplements would affect the function of stem cells just wasn’t available. At the time, we knew of a few medications that would definitely be harmful to stem cell activity and we thought the list was fairly short. But research sheds light on new discoveries over time and in many instances serendipitously uncovers information that is unexpected and or different from the hypothesis or expected outcome. In research this is known as a ‘paradoxical effect’; a reaction opposite to that which was predicted or anticipated. So it is with this study. Since much of what we are doing in this study is being done for the first time in history, this is not surprising. As a result of this research, there are a great number of ‘medical firsts’ in the queue to be published. For example, for the first time in history we have seen the transition of skeletal muscle from spastic to flaccid tissue once the neural pathways begin to re-establish signalling. This is because no patient with the type of paralysis left by a chronic debilitating disease such as MS has ever gone far enough into a healing recovery to experience these changes. We have also seen imaging changes post-therapy in lesions within the brain, so significant that these bright white appearing foci have actually vanished without a trace, as reported by neurologists. In order to study this area more completely, we have now engaged a top neuroscientist in this area of research.